Cancer Risk Information Providers (CRIP): Phase III

CRIP III is a self-administered mailed survey of 1500 cancer risk information providers (CRIPs). The questionnaire was developed from the results of the telephone interview guide (P-TIG) of CRIP Phase II and is designed to assess the knowledge, attitudes, behaviors, practices and perceptions (KABPP) of more formally recognized CRIP. The sample will include all CRIP identified (but not necessarily interviewed( in CRIP Phase II (n=250, U.S.; n=250, Canada). A similar CRIP group in the U.K. (N-125) and New Zealand/Australia (n=125) will also be included. The CRIP III questionnaire will also be sent to less formally recognized CRIP. They will be randomly sampled from the CRIP types identified in Phase II as key information providers, but not necessarily formally recognized [i.e., medical oncologists (250), surgical oncologists (250) and family physicians (250); 50% from the U.S. and 50% from Canada]. The total number of respondents will be 1500 CRIP from 5 countries. These data will be collected by mail centrally from Toronto using the Dillman method. Based on previous results, an overall 80% response rate is anticipated. The results will be analyzed using descriptive statistics, log-linear modeling, logistic regression, analysis of variance and regression analysis. The findings of this mailed survey will: (I) provide data for a comprehensive report on persons providing heritable cancer risk information at this time; and (ii) be the basis for a CRIP IV International Consensus Conference to held in month 18 of this project. (Member of CGSC)